NERISSA TORIO: Open Payments
NPI 1558858928 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 24 payments from 13 companies in 2025. Trend: 2023 $44 · 2024 $253 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $172 |
| Novo Nordisk Inc | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| PFIZER INC. | 3 | $52 |
| Dexcom, Inc. | 2 | $51 |
| Corcept Therapeutics | 2 | $46 |
| Lilly USA, LLC | 2 | $35 |
| Mannkind Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: FREESTYLE LIBRE, JARDIANCE, PAXLOVID, Dexcom G6 Transmitter, Korlym, MOUNJARO, AIRSUPRA, FARXIGA.
Industry payments across NV — which companies pay providers there.
